Moderate to Severe Refractory Autoimmune Disease
1 clinical trials · Condition
◉ Watch Moderate to Severe Refractory Autoimmune Disease
| Record | Firm | Date |
|---|---|---|
| A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate-to-Severe Refractory Autoimmune Diseases (NCT07333118) | Grit Biotechnology | 2025-11-07 |
Track Moderate to Severe Refractory Autoimmune Disease automatically
Every clearance here is in the API, with alerts when new ones post.